Literature DB >> 30355577

APRT deficiency: the need for early diagnosis.

Aamira Huq1, Kushma Nand2, Rajiv Juneja3, Ingrid Winship4,5.   

Abstract

Adenine phosphoribosyltransferase (APRT) deficiency is a rare autosomal recessive disorder which leads to accumulation of poorly soluble 2,8-dihydroxyadenine in kidneys resulting in nephrolithiasis as well as chronic kidney disease from crystal nephropathy. This report describes a 55-year-old previously fit man who presented with shortness of breath and the investigative pathway that eventually led to a diagnosis of APRT deficiency. Early diagnosis has aided in timely institution of allopurinol, thereby improving his renal function and possibility of weaning off renal replacement therapy. Genetic testing has enabled early identification of other family members at risk and prevention of renal failure by commencing xanthine oxidoreductase (XOR) inhibitors. The issues surrounding kidney donation by a member of this family are also discussed. This case represents the importance of awareness and recognition of the signs and symptoms of this rare condition, complications of which can be easily prevented by early institution of XOR inhibitor therapy. © BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  chronic renal failure; genetic screening / counselling; renal intervention; renal transplantation; urinary and genital tract disorders

Mesh:

Substances:

Year:  2018        PMID: 30355577      PMCID: PMC6202999          DOI: 10.1136/bcr-2018-225742

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  25 in total

Review 1.  Azathioprine and allopurinol: A two-edged interaction.

Authors:  Richard B Gearry; Andrew S Day; Murray L Barclay; Rupert W L Leong; Miles P Sparrow
Journal:  J Gastroenterol Hepatol       Date:  2010-04       Impact factor: 4.029

2.  Adenine phosphoribosyltransferase deficiency and renal allograft dysfunction.

Authors:  B Benedetto; R Madden; A Kurbanov; G Braden; J Freeman; G S Lipkowitz
Journal:  Am J Kidney Dis       Date:  2001-05       Impact factor: 8.860

3.  Adenine phosphoribosyltransferase deficiency in children.

Authors:  Jérôme Harambat; Guillaume Bollée; Michel Daudon; Irène Ceballos-Picot; Albert Bensman
Journal:  Pediatr Nephrol       Date:  2012-01-03       Impact factor: 3.714

4.  Child's urinary lithiasis revealing a complete deficit in adenine phosphoribosyl transferase.

Authors:  H Debray; P Cartier; A Temstet; J Cendron
Journal:  Pediatr Res       Date:  1976-08       Impact factor: 3.756

5.  Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis.

Authors:  Jan Halbritter; Michelle Baum; Ann Marie Hynes; Sarah J Rice; David T Thwaites; Zoran S Gucev; Brittany Fisher; Leslie Spaneas; Jonathan D Porath; Daniela A Braun; Ari J Wassner; Caleb P Nelson; Velibor Tasic; John A Sayer; Friedhelm Hildebrandt
Journal:  J Am Soc Nephrol       Date:  2014-10-08       Impact factor: 10.121

6.  Phenotype and genotype characterization of adenine phosphoribosyltransferase deficiency.

Authors:  Guillaume Bollée; Cécile Dollinger; Lucile Boutaud; Delphine Guillemot; Albert Bensman; Jérôme Harambat; Patrice Deteix; Michel Daudon; Bertrand Knebelmann; Irène Ceballos-Picot
Journal:  J Am Soc Nephrol       Date:  2010-02-11       Impact factor: 10.121

Review 7.  2,8-Dihydroxyadenine urolithiasis: a not so rare inborn error of purine metabolism.

Authors:  Irène Ceballos-Picot; Michel Daudon; Jérôme Harambat; Albert Bensman; Bertrand Knebelmann; Guillaume Bollée
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2014       Impact factor: 1.381

8.  Comparison of the effect of allopurinol and febuxostat on urinary 2,8-dihydroxyadenine excretion in patients with Adenine phosphoribosyltransferase deficiency (APRTd): A clinical trial.

Authors:  Vidar O Edvardsson; Hrafnhildur L Runolfsdottir; Unnur A Thorsteinsdottir; Inger M Sch Agustsdottir; G Steinunn Oddsdottir; Finnur Eiriksson; David S Goldfarb; Margret Thorsteinsdottir; Runolfur Palsson
Journal:  Eur J Intern Med       Date:  2017-12-12       Impact factor: 4.487

9.  Recurrent 2,8-dihydroxyadenine nephropathy: a rare but preventable cause of renal allograft failure.

Authors:  M Zaidan; R Palsson; E Merieau; E Cornec-Le Gall; A Garstka; U Maggiore; P Deteix; M Battista; E-R Gagné; I Ceballos-Picot; J-P Duong Van Huyen; C Legendre; M Daudon; V O Edvardsson; B Knebelmann
Journal:  Am J Transplant       Date:  2014-10-10       Impact factor: 8.086

10.  Adenine phosphoribosyltransferase (APRT) deficiency: a new genetic mutation with early recurrent renal stone disease in kidney transplantation.

Authors:  Vanna Micheli; Fabio Massarino; Gabriella Jacomelli; Matteo Bertelli; Maria Rita Corradi; Andrea Guerrini; Antonino Cucchiara; Jean Louis Ravetti; Laura Negretti; Giuseppe Cannella
Journal:  NDT Plus       Date:  2010-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.